NEWS

September 24, 2019
Neurogene Appoints Christine Mikail as President
Learn more >
July 25, 2019
Neurogene Offers Access to Genetic Testing to Patients Suspected of Having a Lysosomal Storage Disease
Learn more >
July 18, 2019
Neurogene Initiates Natural History Study of Charcot-Marie Tooth Disease (CMT4J)
Learn more >
July 9, 2019
Neurogene Initiates Natural History Study of CLN7 and CLN5, Two Forms of Batten Disease
Learn more >
April 23, 2019
Neurogene Initiates Natural History Study of Aspartylglucosaminuria (AGU)
Learn more >
February 27, 2019
Neurogene Appoints Industry Leaders Dr. Sukumar Nagendran and Dr. Serge Stankovic to Board of Directors
Learn more >
February 12, 2019
Neurogene Raises $68.5 Million in Series A Financing to Advance Multiple Programs in Devastating Neurological Diseases
Learn more >
February 7, 2019
Neurogene Announces Presentation of Preclinical Data for Gene Therapies to Treat AGU and CMT4J, Two Rare and Devastating Neurodegenerative Disorders
Learn more >
January 23, 2019
Neurogene Appoints Stuart Cobb, Ph.D. as Chief Scientific Officer
Learn more >

For MEDIA INQUIRIES

Sara Green
sgreen@tenbridgecommunications.com
617-233-1714